Comparison of Video and Direct Laryngoscopy in Obese Patients During Surgery
Launched by HARRAN UNIVERSITY · May 14, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different tools are used to help patients breathe during surgery, specifically for those who are obese. It compares two types of video laryngoscopes and a standard laryngoscope to see which one leads to fewer complications, such as a sore throat, hoarseness, nausea, and vomiting, after surgery. The goal is to understand which method is safer and more effective for obese patients who need to be put under general anesthesia.
To be eligible for the study, participants must be between 18 and 65 years old, have a body mass index (BMI) of 30 or higher, and be scheduled for elective (planned) surgery that requires intubation, which is when a tube is placed in the airway to help with breathing. Participants will need to give their written consent to join. During the trial, they can expect to be monitored for any complications in the recovery room before they go home. This study is currently recruiting participants, and it aims to gather important information to improve care for obese patients during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 65 years
- • Body mass index (BMI) ≥30 kg/m²
- • ASA physical status I or II
- • Scheduled for elective surgery
- • Requiring endotracheal intubation
- • Provided written informed consent
- Exclusion Criteria:
- • Refusal to participate in the study
- • ASA physical status III, IV, or V
- • Advanced cardiopulmonary disease
- • Cervical spine movement limitation
- • Pregnancy
- • Coagulopathy
- • Emergency surgery indication
- • Known or anticipated difficult airway
- • Severe anatomical deformity of the airway
About Harran University
Harran University is a distinguished academic institution committed to advancing healthcare through innovative research and clinical trials. With a focus on enhancing patient outcomes, the university leverages its multidisciplinary expertise to conduct rigorous scientific investigations. Harran University fosters collaboration among researchers, clinicians, and industry partners to explore novel therapeutic approaches and improve clinical practices. Through its dedication to ethical standards and patient safety, Harran University aims to contribute significantly to the body of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
şanlıurfa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported